Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase-Reference-Cited by-同舟云学术

Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase

Published:2008-09 Issue:17 Volume:18 Page:4838-4843
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Keith John M.,Apodaca Richard,Xiao Wei,Seierstad Mark,Pattabiraman Kanaka,Wu Jiejun,Webb Michael,Karbarz Mark J.,Brown Sean,Wilson Sandy,Scott Brian,Tham Chui-Se,Luo Lin,Palmer James,Wennerholm Michelle,Chaplan Sandra,Breitenbucher J. Guy

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference29 articles.

1. Structure of a cannabinoid receptor and functional expression of the cloned cDNA

2. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

3. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

4. Fatty Acid Amide Hydrolase Competitively Degrades Bioactive Amides and Esters through a Nonconventional Catalytic Mechanism

5. Fatty acid amide hydrolase substrate specificity

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2,1,3-Benzothiadiazoles Are Versatile Fluorophore Building Blocks for the Design of Analyte-Sensing Optical Devices;Chemosensors;2024-08-07

2. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years;Pharmacological Reviews;2023-05-10

3. Endocannabinoid hydrolases differentially distribute in platelets and red blood cells and are differentially released by thrombin;PROSTAG OTH LIPID M;2023

4. Endocannabinoid hydrolases differentially distribute in platelets and red blood cells and are differentially released by thrombin;Prostaglandins & Other Lipid Mediators;2023-02

5. Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors;Archiv der Pharmazie;2022-05-02